42 articles for SW Kaldor
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.

Eli Lilly
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.

Agouron Pharmaceuticals
Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.

Takeda California
Structure-based drug design of nonpeptidic P
2 substituents for HIV-1 protease inhibitors

TBA
Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease

TBA
A systematic study of P
1–P
3 spanning sidechains for the inhibition of HIV-1 protease

TBA
Glutamine-derived aldehydes for the inhibition of human rhinovirus 3C protease

TBA
New dipeptide isosteres useful for the inhibition of HIV-1 protease

TBA
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations.

Kinnate Biopharma
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition.

Kinnate Biopharma
Azetidinones as vasopressin V1a antagonists.

Lehigh University
Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1).

Fount Therapeutics
Expedited discovery of second generation NK-1 antagonists: identification of a nonbasic aryloxy substituent.

Eli Lilly
Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors.

Celgene Quanticel Research
BRD4 inhibitor compound in solid form and preparation method therefor and use thereof

CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)
2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase

Oxford Drug Design
Substituted pyridines as PARP1 inhibitors

Xinthera
Inhibitors of VAP-1

Acucela
JAK kinase inhibitor compounds for treatment of respiratory disease

Theravance Biopharma R&D Ip
Pharmaceutical compounds

Sareum
Therapeutically active compounds and their methods of use

Servier Pharmaceuticals
Glucagon-like peptide1 receptor agonists

Eli Lilly
Solid forms of a plasma kallikrein inhibitor and salts thereof

Kalvista Pharmaceuticals
Anti-inflammatory compound, and preparation and use thereof

E-Nitiate Biopharmaceuticals (Hangzhou)
Dihydroquinolinones for medical treatment

C4 Therapeutics
Inhibitors of RAF kinases

Kinnate Biopharma
RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals
Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors

Bayer Aktiengesellschaft
Pharmaceutical compounds

Almac Discovery
Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators

Janssen Pharmaceutica
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists

Nimbus Saturn
Thiazole derivative and applications

East China University of Science and Technology
Dihydroxybenzamide compound having HSP90 inhibitory activity or pharmaceutically acceptable salt thereof, and medical use thereof

Oncozen
Nitrogen-containing heterocyclic amide compound and pharmaceutical use thereof

Japan Tobacco
Arginase inhibitors as therapeutics

Mars
Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.

Stony Brook University
Azetidine-substituted quinoxalines as opioid receptor like-1 modulators

Purdue Pharma
Reverse Biosynthesis: Generating Combinatorial Pools of Drug Leads from Enzyme-Mediated Fragmentation of Natural Products.

The University of Sydney
Cinnamoyl inhibitors of transglutaminase

University of Ottawa
Azetidine derivative and antidepressant composition including the same

Korea Institute of Science and Technology
Spiro-oxindole MDM2 antagonists

University of Michigan